US Stock MarketDetailed Quotes

XTNT Xtant Medical

Watchlist
  • 0.7299
  • +0.0099+1.38%
Trading May 30 13:30 ET
95.05MMarket Cap0.00P/E (TTM)

Xtant Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
55.34%27.87M
57.50%91.3M
84.07%28.11M
73.00%25.02M
32.43%20.23M
38.46%17.94M
4.90%57.97M
9.31%15.27M
4.97%14.46M
2.02%15.28M
Operating revenue
55.34%27.87M
57.50%91.3M
84.07%28.11M
73.00%25.02M
32.43%20.23M
38.56%17.94M
5.12%57.97M
9.44%15.27M
5.23%14.46M
2.24%15.28M
Cost of revenue
42.72%10.57M
38.73%35.84M
57.54%10.97M
47.50%9.69M
12.60%7.77M
37.19%7.41M
13.43%25.83M
10.98%6.96M
-0.30%6.57M
26.43%6.9M
Gross profit
64.22%17.3M
72.60%55.47M
106.32%17.14M
94.20%15.33M
48.78%12.46M
39.37%10.54M
-1.09%32.14M
7.94%8.31M
9.80%7.9M
-11.99%8.37M
Operating expense
71.50%20.77M
68.74%65.63M
108.80%20.94M
91.09%18.72M
43.17%13.85M
28.97%12.11M
7.01%38.89M
4.41%10.03M
13.43%9.8M
-3.32%9.67M
Selling and administrative expenses
69.58%20.25M
69.28%64.29M
108.73%20.45M
90.54%18.23M
44.92%13.67M
30.07%11.94M
7.06%37.98M
3.63%9.8M
14.25%9.57M
-3.38%9.43M
-Selling and marketing expense
76.64%12.46M
70.73%38.44M
98.63%11.58M
89.88%11.09M
54.65%8.72M
35.42%7.05M
7.09%22.52M
9.77%5.83M
10.84%5.84M
0.82%5.64M
-General and administrative expense
59.40%7.79M
67.18%25.85M
123.58%8.87M
91.58%7.14M
30.47%4.95M
23.05%4.88M
7.01%15.46M
-4.25%3.97M
20.02%3.73M
-9.01%3.8M
Research and development costs
202.87%527K
46.01%1.34M
112.07%492K
113.97%490K
-25.31%180K
-18.31%174K
5.17%915K
53.64%232K
-12.60%229K
-0.82%241K
Operating profit
-120.18%-3.47M
-50.38%-10.16M
-120.77%-3.81M
-78.16%-3.39M
-7.00%-1.39M
13.93%-1.58M
-75.27%-6.76M
9.79%-1.72M
-31.49%-1.9M
-164.77%-1.3M
Net non-operating interest income expense
-70.76%-835K
-67.91%-2.79M
-72.84%-802K
-61.82%-712K
-97.98%-786K
-36.21%-489K
-66.93%-1.66M
0.43%-464K
-33.74%-440K
-99.50%-397K
Non-operating interest income
--0
380.65%149K
-48.39%16K
--48K
--0
--86K
--31K
--31K
--0
--0
Non-operating interest expense
45.22%835K
73.64%2.94M
65.25%818K
72.73%760K
97.98%786K
60.17%575K
70.05%1.69M
6.22%495K
33.74%440K
99.50%397K
Other net income (expense)
-27K
11.91M
882K
11.03M
Gain on sale of security
---39K
--265K
----
----
----
----
----
----
----
----
Special income (charges)
----
--11.69M
--666K
--11.03M
----
----
--0
--0
--0
----
-Less:Restructuring and merger&acquisition
----
---11.69M
---666K
---11.03M
----
----
--0
--0
--0
----
Other non- operating income (expenses)
--12K
---49K
----
----
----
----
----
----
----
----
Income before tax
-109.78%-4.33M
87.68%-1.04M
-70.29%-3.73M
396.20%6.93M
-28.29%-2.18M
5.71%-2.07M
-73.56%-8.42M
7.95%-2.19M
-31.91%-2.34M
-145.94%-1.7M
Income tax
423.08%68K
-2,559.42%-1.7M
2,647.62%577K
-17,792.31%-2.3M
0.00%13K
-43.48%13K
69K
122.34%21K
-56.67%13K
-69.77%13K
Net income
-111.74%-4.4M
107.78%660K
-94.79%-4.3M
492.31%9.23M
-28.07%-2.19M
6.10%-2.08M
-74.98%-8.49M
3.24%-2.21M
-30.43%-2.35M
-133.29%-1.71M
Net income continuous Operations
-111.74%-4.4M
107.78%660K
-94.79%-4.3M
492.31%9.23M
-28.07%-2.19M
6.10%-2.08M
-74.98%-8.49M
3.24%-2.21M
-30.43%-2.35M
-133.29%-1.71M
Minority interest income
Net income attributable to the parent company
-111.74%-4.4M
107.78%660K
-94.79%-4.3M
492.31%9.23M
-28.07%-2.19M
6.10%-2.08M
-74.98%-8.49M
3.24%-2.21M
-30.43%-2.35M
-133.29%-1.71M
Preferred stock dividends
Other preferred stock dividends
-113.38%-1.01M
-471K
Net income attributable to common stockholders
-111.26%-3.4M
107.78%660K
-94.79%-4.3M
492.31%9.23M
-28.07%-2.19M
27.38%-1.61M
-74.98%-8.49M
3.24%-2.21M
-30.43%-2.35M
-133.29%-1.71M
Basic earnings per share
-50.00%-0.03
111.11%0.01
-50.00%-0.03
333.33%0.07
0.00%-0.02
33.33%-0.02
-50.00%-0.09
33.33%-0.02
-50.00%-0.03
-100.00%-0.02
Diluted earnings per share
-50.00%-0.03
111.11%0.01
-50.00%-0.03
333.33%0.07
0.00%-0.02
33.33%-0.02
-50.00%-0.09
33.33%-0.02
-50.00%-0.03
-100.00%-0.02
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 55.34%27.87M57.50%91.3M84.07%28.11M73.00%25.02M32.43%20.23M38.46%17.94M4.90%57.97M9.31%15.27M4.97%14.46M2.02%15.28M
Operating revenue 55.34%27.87M57.50%91.3M84.07%28.11M73.00%25.02M32.43%20.23M38.56%17.94M5.12%57.97M9.44%15.27M5.23%14.46M2.24%15.28M
Cost of revenue 42.72%10.57M38.73%35.84M57.54%10.97M47.50%9.69M12.60%7.77M37.19%7.41M13.43%25.83M10.98%6.96M-0.30%6.57M26.43%6.9M
Gross profit 64.22%17.3M72.60%55.47M106.32%17.14M94.20%15.33M48.78%12.46M39.37%10.54M-1.09%32.14M7.94%8.31M9.80%7.9M-11.99%8.37M
Operating expense 71.50%20.77M68.74%65.63M108.80%20.94M91.09%18.72M43.17%13.85M28.97%12.11M7.01%38.89M4.41%10.03M13.43%9.8M-3.32%9.67M
Selling and administrative expenses 69.58%20.25M69.28%64.29M108.73%20.45M90.54%18.23M44.92%13.67M30.07%11.94M7.06%37.98M3.63%9.8M14.25%9.57M-3.38%9.43M
-Selling and marketing expense 76.64%12.46M70.73%38.44M98.63%11.58M89.88%11.09M54.65%8.72M35.42%7.05M7.09%22.52M9.77%5.83M10.84%5.84M0.82%5.64M
-General and administrative expense 59.40%7.79M67.18%25.85M123.58%8.87M91.58%7.14M30.47%4.95M23.05%4.88M7.01%15.46M-4.25%3.97M20.02%3.73M-9.01%3.8M
Research and development costs 202.87%527K46.01%1.34M112.07%492K113.97%490K-25.31%180K-18.31%174K5.17%915K53.64%232K-12.60%229K-0.82%241K
Operating profit -120.18%-3.47M-50.38%-10.16M-120.77%-3.81M-78.16%-3.39M-7.00%-1.39M13.93%-1.58M-75.27%-6.76M9.79%-1.72M-31.49%-1.9M-164.77%-1.3M
Net non-operating interest income expense -70.76%-835K-67.91%-2.79M-72.84%-802K-61.82%-712K-97.98%-786K-36.21%-489K-66.93%-1.66M0.43%-464K-33.74%-440K-99.50%-397K
Non-operating interest income --0380.65%149K-48.39%16K--48K--0--86K--31K--31K--0--0
Non-operating interest expense 45.22%835K73.64%2.94M65.25%818K72.73%760K97.98%786K60.17%575K70.05%1.69M6.22%495K33.74%440K99.50%397K
Other net income (expense) -27K11.91M882K11.03M
Gain on sale of security ---39K--265K--------------------------------
Special income (charges) ------11.69M--666K--11.03M----------0--0--0----
-Less:Restructuring and merger&acquisition -------11.69M---666K---11.03M----------0--0--0----
Other non- operating income (expenses) --12K---49K--------------------------------
Income before tax -109.78%-4.33M87.68%-1.04M-70.29%-3.73M396.20%6.93M-28.29%-2.18M5.71%-2.07M-73.56%-8.42M7.95%-2.19M-31.91%-2.34M-145.94%-1.7M
Income tax 423.08%68K-2,559.42%-1.7M2,647.62%577K-17,792.31%-2.3M0.00%13K-43.48%13K69K122.34%21K-56.67%13K-69.77%13K
Net income -111.74%-4.4M107.78%660K-94.79%-4.3M492.31%9.23M-28.07%-2.19M6.10%-2.08M-74.98%-8.49M3.24%-2.21M-30.43%-2.35M-133.29%-1.71M
Net income continuous Operations -111.74%-4.4M107.78%660K-94.79%-4.3M492.31%9.23M-28.07%-2.19M6.10%-2.08M-74.98%-8.49M3.24%-2.21M-30.43%-2.35M-133.29%-1.71M
Minority interest income
Net income attributable to the parent company -111.74%-4.4M107.78%660K-94.79%-4.3M492.31%9.23M-28.07%-2.19M6.10%-2.08M-74.98%-8.49M3.24%-2.21M-30.43%-2.35M-133.29%-1.71M
Preferred stock dividends
Other preferred stock dividends -113.38%-1.01M-471K
Net income attributable to common stockholders -111.26%-3.4M107.78%660K-94.79%-4.3M492.31%9.23M-28.07%-2.19M27.38%-1.61M-74.98%-8.49M3.24%-2.21M-30.43%-2.35M-133.29%-1.71M
Basic earnings per share -50.00%-0.03111.11%0.01-50.00%-0.03333.33%0.070.00%-0.0233.33%-0.02-50.00%-0.0933.33%-0.02-50.00%-0.03-100.00%-0.02
Diluted earnings per share -50.00%-0.03111.11%0.01-50.00%-0.03333.33%0.070.00%-0.0233.33%-0.02-50.00%-0.0933.33%-0.02-50.00%-0.03-100.00%-0.02
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg